These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2074507)

  • 1. Hematuria screening for bladder cancer.
    Messing EM; Vaillancourt A
    J Occup Med; 1990 Sep; 32(9):838-45. PubMed ID: 2074507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of home dipstick testing for hematuria.
    Madeb R; Messing EM
    World J Urol; 2008 Feb; 26(1):19-24. PubMed ID: 18040694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer screening at the Dupont Chambers Works: a new initiative.
    Mason TJ; Vogler WJ
    J Occup Med; 1990 Sep; 32(9):874-7. PubMed ID: 2074511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational bladder cancer: from cohort study to biologic molecular marker.
    Matsumoto K; Irie A; Satoh T; Kuruma H; Arakawa T; Baba S
    Med Sci Monit; 2005 Oct; 11(10):RA311-5. PubMed ID: 16192913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematuria home screening: repeat testing results.
    Messing EM; Young TB; Hunt VB; Newton MA; Bram LL; Vaillancourt A; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
    J Urol; 1995 Jul; 154(1):57-61. PubMed ID: 7776456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
    Hedelin H; Jonsson K; Salomonsson K; Boman H
    Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks.
    Messing EM; Young TB; Hunt VB; Emoto SE; Wehbie JM
    J Urol; 1987 May; 137(5):919-22. PubMed ID: 2437335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
    Messing EM; Young TB; Hunt VB; Gilchrist KW; Newton MA; Bram LL; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
    Urology; 1995 Mar; 45(3):387-96; discussion 396-7. PubMed ID: 7879333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community study of bladder cancer screening by the detection of occult urinary bleeding.
    Britton JP; Dowell AC; Whelan P; Harris CM
    J Urol; 1992 Sep; 148(3):788-90. PubMed ID: 1512826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer screening.
    Kryger JV; Messing E
    Semin Oncol; 1996 Oct; 23(5):585-97. PubMed ID: 8893869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of hematuria home screening for bladder cancer in men.
    Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
    Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of hematuria home screening for bladder cancer in men.
    Cai T; Bartoletti R
    Cancer; 2007 May; 109(9):1923-4; author reply 1924. PubMed ID: 17357998
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
    Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
    Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of hematuria at a printing company.
    Sinclair MI; McNeil JJ; Atkins RC; Turnidge JD; Wood CJ; Matthews BJ
    J Occup Med; 1993 Oct; 35(10):1055-61. PubMed ID: 8271078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary markers in screening patients with hematuria.
    Chiong E; Gaston KE; Grossman HB
    World J Urol; 2008 Feb; 26(1):25-30. PubMed ID: 18060548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
    Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
    BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home screening for hematuria: results of a multiclinic study.
    Messing EM; Young TB; Hunt VB; Roecker EB; Vaillancourt AM; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
    J Urol; 1992 Aug; 148(2 Pt 1):289-92. PubMed ID: 1635120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.